TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › Operating IncomeTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2007: $2.40B2008: $1.15B2009: $2.40B2010: $3.87B2011: $3.11B2012: $2.21B2013: $1.65B2016: $2.15B2017: -$17.48B2018: -$1.64B2019: -$443.00M2020: -$3.57B2021: $1.72B2022: -$2.20B2023: $433.00M2024: -$303.00M2025: $2.16B$2.16B2007Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$2.16B+811.9%2024-$303.00M-170.0%2023$433.00M+119.7%2022-$2.20B-228.0%2021$1.72B+148.0%2020-$3.57B-706.3%2019-$443.00M+72.9%2018-$1.64B+90.6%2017-$17.48B-911.7%2016$2.15B—2013$1.65B-25.2%2012$2.21B-29.1%2011$3.11B-19.7%2010$3.87B+61.0%2009$2.40B+110.0%2008$1.15B-52.2%2007$2.40B—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share